SKI Market

Indian Indices

Sensex

81,666.46 943.52
( 1.17%)

Global Indices

Nasdaq

49,433.27 519.79
(1.06%)

Dow Jones

6,997.90 37.87
(0.54%)

Hang Seng

52,813.31 -509.54
(-0.96%)

Nikkei 225

10,322.91 99.37
(0.97%)

Forex

USD-INR

91.61 -0.04
(-0.05%)

EUR-INR

108.55 -0.05
(-0.05%)

GBP-INR

125.35 -0.06
(-0.05%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Venus Remedies Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

526953

INE411B01019

467.2458657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VENUSREM

1060

EPS(TTM)

Face Value()

Div & Yield %

52.85

Back

urja global ltd

Bajaj Finance consolidated net profit rises 21.89% in the September 2025 quarter

Nov 11,2025

Net profit of Bajaj Finance rose 21.89% to Rs 4875.36 crore in the quarter ended September 2025 as against Rs 3999.73 crore during the previous quarter ended September 2024. Sales rose 18.71% to Rs 19867.45 crore in the quarter ended September 2025 as against Rs 16736.58 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	19867.45	16736.58	19
OPM %	69.82	70.23	-
PBDT	6866.19	5611.52	22
PBT	6608.13	5401.48	22
NP	4875.36	3999.73	22

81,666.46 943.52 ( 1.17%)

49,433.27 519.79 (1.06%)

6,997.90 37.87 (0.54%)

52,813.31 -509.54 (-0.96%)

10,322.91 99.37 (0.97%)

91.61 -0.04 (-0.05%)

108.55 -0.05 (-0.05%)

125.35 -0.06 (-0.05%)

0.59 0.00 (-0.07%)